Skip to main content
. 2019 Nov 29;7(3):267–274. doi: 10.14744/nci.2019.31384

TABLE 3.

Multivariate analysis for survival according to stages

Stage II-III Stage IV


HR 95.0% CI p HR 95.0% CI p
ECOG PS 3–4 vs. 0–2 6.138 1.212–31.075 0.028 ECOG PS 3–4 vs. 0–2 3.313 1.141–9.693 0.004
Surgery Yes vs. no 0.229 0.092–0.570 0.002 Grade III vs. I-II 3.397 1.551–7.439 0.002
Stage III vs. II 3.195 1.111–9.183 0.031 Liver metastasis Yes vs. no 2.537 1.134–5.672 0.023
Recurrence Yes vs. no 24.128 6.455–90.180 <0.001 CT vs. BSC 0.156 0.069–0.348 <0.001

CI: Confidence interval; CT: Chemotherapy; BSC: Best supportive care; ECOG PS: Eastern Cooperative Oncology Group Performance Status; HR: Hazard ratio.